The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway.
 
Sébastien Perreault
Stock and Other Ownership Interests - Novocure
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai
Research Funding - Novartis
 
Dorsa Sadat Kiaei
No Relationships to Disclose
 
Mathieu Dehaes
No Relationships to Disclose
 
Valérie Larouche
No Relationships to Disclose
 
Uri Tabori
No Relationships to Disclose
 
Cynthia Hawkin
No Relationships to Disclose
 
Sarah Lippé
No Relationships to Disclose
 
Benjamin Ellezam
No Relationships to Disclose
 
Edith Cantin
No Relationships to Disclose
 
Marie-Ève Routhier
No Relationships to Disclose
 
Maxime Caru
No Relationships to Disclose
 
Stephanie Vairy
No Relationships to Disclose
 
Geneviève Legault
No Relationships to Disclose
 
Eric Bouffet
Consulting or Advisory Role - Novartis
Research Funding - Roche (Inst)
 
Vijay Ramaswamy
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca Canada
 
Hallie Coltin
No Relationships to Disclose
 
Lucie Lafay-Cousin
No Relationships to Disclose
 
Juliette Hukin
Consulting or Advisory Role - AstraZeneca Canada
 
Craig Erker
No Relationships to Disclose
 
Nada Jabado
No Relationships to Disclose